This is a preprint.
A 6-minute Limb Function Assessment for Therapeutic Testing in Experimental Peripheral Artery Disease Models
- PMID: 38585832
- PMCID: PMC10996543
- DOI: 10.1101/2024.03.21.586197
A 6-minute Limb Function Assessment for Therapeutic Testing in Experimental Peripheral Artery Disease Models
Abstract
Background: The translation of promising therapies from pre-clinical models of hindlimb ischemia (HLI) to patients with peripheral artery disease (PAD) has been inadequate. While this failure is multifactorial, primary outcome measures in preclinical HLI models and clinical trials involving patients with PAD are not aligned well. For example, laser Doppler perfusion recovery measured under resting conditions is the most used outcome in HLI studies, whereas clinical trials involving patients with PAD primarily assess walking performance. Here, we sought to develop a 6-min limb function test for preclinical HLI models that assess muscular performance and hemodynamics congruently.
Methods: We developed an in situ 6-min limb function test that involves repeated isotonic (shortening) contractions performed against a submaximal load. Continuous measurement of muscle blood flow was performed using laser Doppler flowmetry. Quantification of muscle power, work, and perfusion are obtained across the test. To assess the efficacy of this test, we performed HLI via femoral artery ligation on several mouse strains: C57BL6J, BALBc/J, and MCK-PGC1α (muscle-specific overexpression of PGC1α). Additional experiments were performed using an exercise intervention (voluntary wheel running) following HLI.
Results: The 6-min limb function test was successful at detecting differences in limb function of C57BL6/J and BALBc/J mice subjected to HLI with effect sizes superior to laser Doppler perfusion recovery. C57BL6/J mice randomized to exercise therapy following HLI had smaller decline in muscle power, greater hyperemia, and performed more work across the 6-min limb function test compared to non-exercise controls with HLI. Mice with muscle-specific overexpression of PGC1α had no differences in perfusion recovery in resting conditions, but exhibited greater capillary density, increased muscle mass and absolute force levels, and performed more work across the 6-min limb function test compared to their wildtype littermates without the transgene.
Conclusion: These results demonstrate the efficacy of the 6-min limb function test to detect differences in the response to HLI across several interventions including where traditional perfusion recovery, capillary density, and muscle strength measures were unable to detect therapeutic differences.
Keywords: femoral artery ligation; hindlimb ischemia; peripheral artery disease.
Conflict of interest statement
Conflict of Interest Statement: The authors have declared that no conflict of interest exists.
Figures
![Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10996543/bin/nihpp-2024.03.21.586197v1-f0001.gif)
![Figure 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10996543/bin/nihpp-2024.03.21.586197v1-f0002.gif)
![Figure 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10996543/bin/nihpp-2024.03.21.586197v1-f0003.gif)
![Figure 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10996543/bin/nihpp-2024.03.21.586197v1-f0004.gif)
Similar articles
-
Loss of Id3 (Inhibitor of Differentiation 3) Increases the Number of IgM-Producing B-1b Cells in Ischemic Skeletal Muscle Impairing Blood Flow Recovery During Hindlimb Ischemia.Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):6-18. doi: 10.1161/ATVBAHA.120.315501. Epub 2021 Nov 23. Arterioscler Thromb Vasc Biol. 2022. PMID: 34809449 Free PMC article.
-
The impact of proangiogenic microRNA modulation on blood flow recovery following hind limb ischemia. A systematic review and meta-analysis of animal studies.Vascul Pharmacol. 2021 Dec;141:106906. doi: 10.1016/j.vph.2021.106906. Epub 2021 Sep 10. Vascul Pharmacol. 2021. PMID: 34509635 Review.
-
Photobiomodulation Therapy to Promote Angiogenesis in Diabetic Mice with Hindlimb Ischemia.Photobiomodul Photomed Laser Surg. 2021 Jul;39(7):453-462. doi: 10.1089/photob.2020.4896. Photobiomodul Photomed Laser Surg. 2021. PMID: 34264768
-
Development of a two-stage limb ischemia model to better simulate human peripheral artery disease.Sci Rep. 2020 Feb 26;10(1):3449. doi: 10.1038/s41598-020-60352-4. Sci Rep. 2020. PMID: 32103073 Free PMC article.
-
The efficacy of extraembryonic stem cells in improving blood flow within animal models of lower limb ischaemia.Heart. 2016 Jan;102(1):69-74. doi: 10.1136/heartjnl-2015-308322. Epub 2015 Nov 16. Heart. 2016. PMID: 26573094 Review.
References
-
- Criqui MH, Matsushita K, Aboyans V, Hess CN, Hicks CW, Kwan TW, et al. Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association (vol 144, pg e171, 2021). Circulation. 2021;144(9):E193–E. - PMC - PubMed
-
- Rajagopalan S, Shah M, Luciano A, Crystal R, and Nabel EG. Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve. Circulation. 2001;104(7):753–5. - PubMed
-
- Taniyama Y, Morishita R, Aoki M, Nakagami H, Yamamoto K, Yamazaki K, et al. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease. Gene Therapy. 2001;8(3):181–9. - PubMed
-
- Shimpo M, Ikeda U, Maeda Y, Takahashi M, Miyashita H, Mizukami H, et al. AAV-mediated VEGF gene transfer into skeletal muscle stimulates angiogenesis and improves blood flow in a rat hindlimb ischemia model. Cardiovascular Research. 2002;53(4):993–1001. - PubMed
-
- Mohler ER 3rd, Rajagopalan S, Olin JW, Trachtenberg JD, Rasmussen H, Pak R, et al. Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase I trial. Vasc Med. 2003;8(1):9–13. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources